Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protein restriction during pregnancy alters Cdkn1c silencing, dopamine circuitry and offspring behaviour without changing expression of key neuronal marker genes.
Prodani C, Irvine EE, Sardini A, Gleneadie HJ, Dimond A, Van de Pette M, John R, Kokkinou M, Howes O, Withers DJ, Ungless MA, Merkenschlager M, Fisher AG. Prodani C, et al. Among authors: kokkinou m. Sci Rep. 2024 Apr 12;14(1):8528. doi: 10.1038/s41598-024-59083-7. Sci Rep. 2024. PMID: 38609446 Free PMC article.
Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Petty A, Garcia-Hidalgo A, Halff EF, Natesan S, Withers DJ, Irvine EE, Kokkinou M, Wells LA, Bonsall DR, Tang SP, Veronese M, Howes OD. Petty A, et al. Among authors: kokkinou m. Mol Imaging Biol. 2024 Apr 3. doi: 10.1007/s11307-024-01916-y. Online ahead of print. Mol Imaging Biol. 2024. PMID: 38570447 No abstract available.
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Petty A, Garcia-Hidalgo A, Halff EF, Natesan S, Withers DJ, Irvine EE, Kokkinou M, Wells LA, Bonsall DR, Tang SP, Veronese M, Howes OD. Petty A, et al. Among authors: kokkinou m. Mol Imaging Biol. 2023 Dec;25(6):1054-1062. doi: 10.1007/s11307-023-01865-y. Epub 2023 Oct 23. Mol Imaging Biol. 2023. PMID: 37872462 Free PMC article.
Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
Halff EF, Natesan S, Bonsall DR, Veronese M, Garcia-Hidalgo A, Kokkinou M, Tang SP, Riggall LJ, Gunn RN, Irvine EE, Withers DJ, Wells LA, Howes OD. Halff EF, et al. Among authors: kokkinou m. Mol Imaging. 2022 Oct 28;2022:4419221. doi: 10.1155/2022/4419221. eCollection 2022. Mol Imaging. 2022. PMID: 36721730 Free PMC article.
Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.
Kokkinou M, Beishon LC, Smailagic N, Noel-Storr AH, Hyde C, Ukoumunne O, Worrall RE, Hayen A, Desai M, Ashok AH, Paul EJ, Georgopoulou A, Casoli T, Quinn TJ, Ritchie CW. Kokkinou M, et al. Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD010945. doi: 10.1002/14651858.CD010945.pub2. Cochrane Database Syst Rev. 2021. PMID: 33566374 Free PMC article.
The Cannabinoid CB1 Receptor in Schizophrenia.
Borgan F, Kokkinou M, Howes O. Borgan F, et al. Among authors: kokkinou m. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):646-659. doi: 10.1016/j.bpsc.2020.06.018. Epub 2020 Jul 6. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021. PMID: 33077399 Review.
15 results